Concepedia

Doreen Cross‐Doersen

DC

Statistics

Publications

18

Citations

379

H-Index

13

Active since

1988

Affiliations

Procter & Gamble (United States)(Current)

University of Cincinnati Medical Center

Marion Local Schools

University of Cincinnati

Doreen Cross‐Doersen is an author at Procter & Gamble (United States) specializing in pharmacology, medicinal chemistry, and ligand binding.

Publications per year

1988–2008

18

Publications

18

Irreversible inhibition of S-adenosylmethionine decarboxylase in Plasmodium falciparum-infected erythrocytes: Growth inhibition in vitro

Paul S. Wright, T L Byers, Doreen Cross‐Doersen et al. · Biochemical Pharmacology · 1991 · 52 citations

, , +12

Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.

A J Bitonti, Jennifer Dumont, Trudy L. Bush et al. · PubMed · 1994 · 39 citations

, , +16

A Ribonucleotide Reductase Inhibitor, MDL 101,731, Induces Apoptosis and Elevates TRPM-2 mRNA Levels in Human Prostate Tumor Xenografts

Paul S. Wright, Doreen Cross‐Doersen, John P.H. Th'ng et al. · Experimental Cell Research · 1996 · 32 citations

, , +6

Sub-Nanomolar hMC1R Agonists by End-Capping of the Melanocortin Tetrapeptide His-d-Phe-Arg-Trp-NH2

L. N. Koikov, Frank H. Ebetino, Mark G. Solinsky et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 31 citations · Full text

, , +11

Effects of α-difluoromethylornithine on protein synthesis and synthesis of the variant-specific glycoprotein (VSG) in <i>Trypanosoma brucei brucei</i>

Alan J. Bitonti, Doreen Cross‐Doersen, Peter P. McCann · Biochemical Journal · 1988 · 24 citations · Full text

, , +14

1–5 of 18